Human lysozyme inhibits the in vitro aggregation of Aβ peptides, which in vivo are associated with Alzheimer's disease†
Abstract
Alzheimer's disease is a neurodegenerative disorder characterized by accumulation of Aβ
* Corresponding authors
a Gorlaeus Laboratory, Leiden Institute of Chemistry, Leiden University, 2300RA Leiden, The Netherlands
b
Department of Biochemistry and Biophysics, Stockholm University, SE-10691 Stockholm, Sweden
E-mail:
Abrahams@chem.leidenuniv.nl
Alzheimer's disease is a neurodegenerative disorder characterized by accumulation of Aβ
J. Luo, S. K. T. S. Wärmländer, A. Gräslund and J. P. Abrahams, Chem. Commun., 2013, 49, 6507 DOI: 10.1039/C3CC42325E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content